Automated Deductions Management for CPGs

Deductions, also known as chargebacks, happen when retailers or distributors don't pay their invoices in full to CPGs and manufacturers — and the $ can add up fast! That’s why it’s so important to assess them quickly, see if they’re actually valid, and determine if you should push to get that money back. 

• Read more about Automated Deductions Management for CPGs

How DSCSA Boosts Crisis Resilience: Strengthening Pharmacies and Hospitals

This article explores how the Drug Supply Chain Security Act (DSCSA) enhances crisis resilience for pharmacies and hospitals by improving product traceability. It highlights the critical role DSCSA plays during supply chain disruptions caused by natural disasters, such as Hurricane Helene, enabling healthcare providers to maintain access to essential medications and ensure patient safety. By leveraging DSCSA’s serialized data and chain of custody insights, pharmacies and hospitals can proactively address challenges and strengthen their operational preparedness.

• Read more about How DSCSA Boosts Crisis Resilience: Strengthening Pharmacies and Hospitals

FTC versus the PBMs: The Battle to Lower Insulin Prices and Reform PBMs

The FTC has filed a lawsuit against major pharmacy benefit managers (PBMs), accusing them of inflating insulin prices through anticompetitive practices that harm patients. This legal battle could lead to significant PBM reforms, ensuring fair pricing for essential medications like insulin. The lawsuit highlights the rising cost of insulin, forcing many patients to ration their medication or go without due to high out-of-pocket expenses. If successful, the case could set a new precedent in holding PBMs accountable and improving access to affordable medications for millions of patients.

• Read more about FTC versus the PBMs: The Battle to Lower Insulin Prices and Reform PBMs

2024 Mid-Year Promotions Trends & Shopper Insights webinar

Consumers are overwhelmed. Will your marketing strategies cut through the noise and support them in their quest for savings? Compared to a year ago, half of consumers are putting more effort into planning their grocery trips. Are you reaching them in the right moments on the right channels as they build their lists?  Shoppers today expect more from the brands and retailers they engage with. How can you earn their favor and their business?

• Read more about 2024 Mid-Year Promotions Trends & Shopper Insights webinar

Delaying DSCSA Enforcement: The Right Decision for all the Right Reasons

Brian Nightengale, EVP and President of Healthcare at Inmar Intelligence, discusses the FDA’s recent decision to delay DSCSA enforcement. The delay offers pharmaceutical supply chain partners more time to fully achieve compliance and address operational challenges related to electronic interoperability and product traceability. Nightengale praises the decision as a thoughtful and proactive move to prevent disruptions in medication distribution while maintaining focus on patient safety and the integrity of the supply chain. He urges industry stakeholders to continue prioritizing efforts toward full DSCSA compliance.

• Read more about Delaying DSCSA Enforcement: The Right Decision for all the Right Reasons

You Previously Qualified for a Small Dispenser DSCSA Exemption. Now What?

This article, originally published in Pharmacy Times, explores the DSCSA exemption for small dispensers and outlines their current and future regulatory obligations. It highlights the importance of staying compliant with key DSCSA requirements, including verifying trading partner licenses, maintaining product tracing documentation, and preparing for full electronic interoperability by the 2026 deadline.

• Read more about You Previously Qualified for a Small Dispenser DSCSA Exemption. Now What?

Rethinking Healthcare: Why Pharmacists Should Be Recognized as Providers

The article advocates for recognizing pharmacists as healthcare providers, enabling them to offer more comprehensive care and help address physician shortages, especially in underserved areas. This change would improve patient outcomes and expand healthcare access.

• Read more about Rethinking Healthcare: Why Pharmacists Should Be Recognized as Providers

PBMs on Notice: NYCBS Victory Signals Major Changes Ahead

New York Cancer and Blood Specialists' $22M win against Caremark challenges PBM DIR fees, sparking potential legal and regulatory shifts. While a major victory for pharmacies, eliminating DIR fees could raise Medicare Part D premiums. Legislative and regulatory changes may reshape PBM practices and impact both pharmacies and beneficiaries.

• Read more about PBMs on Notice: NYCBS Victory Signals Major Changes Ahead

The Final Stretch: Is Your Pharmacy Ready for DSCSA Compliance?

As the November 27, 2024, deadline for full DSCSA compliance looms, the pharmacy industry finds itself in a critical phase of preparation. The recent NACDS Total Store Expo (TSE) in Boston revealed that many pharmacies are facing significant challenges, with the clock ticking down rapidly.

• Read more about The Final Stretch: Is Your Pharmacy Ready for DSCSA Compliance?